{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-196931","form_type":"8-K/A","ticker":null,"cik":"0001822691","company_name":"GreenLight Biosciences Holdings, PBC","filed_at":"2023-07-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.457477+00:00","generated_at":"2026-06-12T23:15:30.140631+00:00","sec_items":["2.01","3.01","3.03","5.01","5.02","5.03","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"GreenLight Biosciences completes going-private merger; stock delisted at $0.30/share","bullets":["Merger with SW ParentCo closed July 24, 2023; stockholders received $0.30 per share cash.","Aggregate consideration ~$9.3M for shares not rolled over; 60.4% of outstanding shares tendered.","Concurrent $52.075M financing led by Fall Line Capital; $15M advanced pre-closing.","CEO Andrey Zarur continues leading combined company; new sole director Clay Mitchell.","Warrant holders must exercise by August 23, 2023 to receive reduced exercise price and $0.0220 Black-Scholes value."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-196931","json":"https://secwatch.observer/filing/0001193125-23-196931.json","markdown":"https://secwatch.observer/filing/0001193125-23-196931.md","text":"https://secwatch.observer/filing/0001193125-23-196931.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822691/000119312523196931/0001193125-23-196931-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822691/000119312523196931/d495956d8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T23:15:30.140631+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"011f79b2a1","claim":"Ganesh Kishore resigned as Director at GreenLight Biosciences Holdings, PBC.","evidence_excerpt":"At the Effective Time, each of Dr. Andrey J. Zarur, Jennifer Pardi, Dr. Charles L. Cooney, Eric O’Brien, Dr. Ganesh Kishore, Dr. Martha Schlicher and Matthew Walker resigned and ceased to be directors of the Company and members of any committee of the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822691/000119312523196931/0001193125-23-196931-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"17788fff0c","claim":"Andrey J. Zarur resigned as Director at GreenLight Biosciences Holdings, PBC.","evidence_excerpt":"At the Effective Time, each of Dr. Andrey J. Zarur, Jennifer Pardi, Dr. Charles L. Cooney, Eric O’Brien, Dr. Ganesh Kishore, Dr. Martha Schlicher and Matthew Walker resigned and ceased to be directors of the Company and members of any committee of the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822691/000119312523196931/0001193125-23-196931-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"2963ab5468","claim":"Eric O’Brien resigned as Director at GreenLight Biosciences Holdings, PBC.","evidence_excerpt":"At the Effective Time, each of Dr. Andrey J. Zarur, Jennifer Pardi, Dr. Charles L. Cooney, Eric O’Brien, Dr. Ganesh Kishore, Dr. Martha Schlicher and Matthew Walker resigned and ceased to be directors of the Company and members of any committee of the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822691/000119312523196931/0001193125-23-196931-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"373445439b","claim":"Clay Mitchell was appointed as President, Chief Financial Officer and Secretary at GreenLight Biosciences Holdings, PBC.","evidence_excerpt":"Effective immediately following these resignations, in connection with the closing of the Merger, Clay Mitchell became the sole director of the Company and President, Chief Financial Officer and Secretary of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822691/000119312523196931/0001193125-23-196931-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President, Chief Financial Officer and Secretary"}],"fact_type":"executive_change"},{"claim_id":"3a77091713","claim":"Charles L. Cooney resigned as Director at GreenLight Biosciences Holdings, PBC.","evidence_excerpt":"At the Effective Time, each of Dr. Andrey J. Zarur, Jennifer Pardi, Dr. Charles L. Cooney, Eric O’Brien, Dr. Ganesh Kishore, Dr. Martha Schlicher and Matthew Walker resigned and ceased to be directors of the Company and members of any committee of the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822691/000119312523196931/0001193125-23-196931-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"4bde4b59d6","claim":"Matthew Walker resigned as Director at GreenLight Biosciences Holdings, PBC.","evidence_excerpt":"At the Effective Time, each of Dr. Andrey J. Zarur, Jennifer Pardi, Dr. Charles L. Cooney, Eric O’Brien, Dr. Ganesh Kishore, Dr. Martha Schlicher and Matthew Walker resigned and ceased to be directors of the Company and members of any committee of the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822691/000119312523196931/0001193125-23-196931-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"8a5f7289e2","claim":"Jennifer Pardi resigned as Director at GreenLight Biosciences Holdings, PBC.","evidence_excerpt":"At the Effective Time, each of Dr. Andrey J. Zarur, Jennifer Pardi, Dr. Charles L. Cooney, Eric O’Brien, Dr. Ganesh Kishore, Dr. Martha Schlicher and Matthew Walker resigned and ceased to be directors of the Company and members of any committee of the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822691/000119312523196931/0001193125-23-196931-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"d1d7117f29","claim":"Martha Schlicher resigned as Director at GreenLight Biosciences Holdings, PBC.","evidence_excerpt":"At the Effective Time, each of Dr. Andrey J. Zarur, Jennifer Pardi, Dr. Charles L. Cooney, Eric O’Brien, Dr. Ganesh Kishore, Dr. Martha Schlicher and Matthew Walker resigned and ceased to be directors of the Company and members of any committee of the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822691/000119312523196931/0001193125-23-196931-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b02bc7667a8953f2b37cbacf7d89bae095381eef","claim":"GreenLight Biosciences Holdings, PBC: Amended and restated bylaws in connection with merger.","evidence_excerpt":"Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, the Company’s certificate of incorporation and bylaws were each amended and restated in their entirety.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822691/000119312523196931/0001193125-23-196931-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"}],"fact_type":"governance_change"},{"claim_id":"e7d061397b6f5983d9087437922f780a41b81a4b","claim":"GreenLight Biosciences Holdings, PBC: Amended and restated certificate of incorporation in connection with merger.","evidence_excerpt":"Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, the Company’s certificate of incorporation and bylaws were each amended and restated in their entirety.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822691/000119312523196931/0001193125-23-196931-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"}],"fact_type":"governance_change"},{"claim_id":"56d3f6a8570c7833bc514200300e6ddd979f9829","claim":"GreenLight Biosciences Holdings, PBC underwent a change of control involving SW ParentCo, Inc. for approximately $9.3 million (closed 2023-07-24).","evidence_excerpt":"On July 24, 2023, the Offer and the Merger were completed as described under “Introductory Note.” The aggregate consideration paid by Merger Sub in the Offer and the Merger to purchase all outstanding shares of Company Common Stock (other than the Rollover Shares), was approximately $9.3 million.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822691/000119312523196931/0001193125-23-196931-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"change of control"},{"label":"Counterparty","value":"SW ParentCo, Inc."},{"label":"Consideration","value":"approximately $9.3 million"},{"label":"Closing","value":"2023-07-24"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}